O. Sanchez (Paris, France), F. ALHAMED ALDUIHI (ALEPPO, Syrian Arab Republic)
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
S. Isik (Ankara, Turkey), E. Kurt (Ankara, Turkey)
|   |
Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study
F. Couturaud (Brest, France), G. Picart (Brest, France), P. Robin (Brest, France), C. Tromeur (Brest, France), R. Le Mao (Brest, France), L. Raj (Brest, Canada), C. Leroyer (Brest, France)
| |
The relationship of thrombus localization with prognosis and chronic tromboembolic pulmonary hypertension in acute pulmonary thromboembolia
B. Harbiyeli (Mersin, Turkey), B. Özkan (Mersin, Turkey), P. Özcan (Mersin, Turkey), Y. Balci (Mersin, Turkey), S. Nayci (Mersin, Turkey), I. Özcan (Mersin, Turkey), E. Ozgur (Mersin, Turkey), C. Özge (Mersin, Turkey)
| |
Pulmonary thromboembolism in childhood: Six years of single center experience
G. Özcan (Ankara, Turkey), H. Çakmakli (Ankara, Turkey), F. Zirek (Ankara, Turkey), T. Kendirli (Ankara, Turkey), T. Uçar (Ankara, Turkey), N. Çobanoglu (Ankara, Turkey)
| |
Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
H. Kilic (Ankara, Turkey), H. Hasanoglu (Ankara, Turkey), A. Karalezli (Ankara, Turkey), H. Hezer (Ankara, Turkey), E. Babaoglu (Ankara, Turkey), M. Er (Ankara, Turkey), E. Parlak (Ankara, Turkey), O. Abuzaina (Ankara, Turkey), D. Oztuna (Ankara, Turkey), E. Arguder (Ankara, Turkey)
| |
Analysis of Causes of Diagnostic Difficulties and Features of Clinical Course of Pulmonary Embolism
N. Popenko (Kyiv, Ukraine)
| |
Influence of cancer diagnosis in patients with pulmonary embolism
J. Hernandez Borge (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), S. Hernández Gómez (Badajoz, Spain), P. Iñigo Naranjo (Badajoz, Spain), M. Benitez-Cano Gamonoso (Badajoz, Spain), M. García García (Badajoz, Spain)
| |
Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital.
P. Kerr (Dublin, Ireland), R. Lee (Dublin, Ireland), R. Poole (Dublin, Ireland), M. Lavin (Dublin, Ireland), P. Houlihan (Dublin, Ireland), B. Mcadam (Dublin, Ireland), M. Lee (Dublin, Ireland), R. Morgan (Dublin, Ireland), E. O'Brien (Dublin, Ireland)
| |
CT abdomen and pelvis to investigate for occult malignancy in patients with first unprovoked pulmonary embolism, is it justified?
E. Hobbs (Liverpool, United Kingdom), A. Heron (Liverpool, United Kingdom), W. Barnsley (Liverpool, United Kingdom), Z. Wahbi (Liverpool, United Kingdom)
| |
Does abdominal-pelvic CT detect occult malignancy in patients with unprovoked pulmonary embolism?
B. Hawramy (Leeds, United Kingdom), J. Ting (Leeds, United Kingdom), D. Ghosh (Leeds, United Kingdom)
| |
What is the incidence of pleural effusions in acute pulmonary emboli?
K. Jackson (Newcastle upon Tyne, United Kingdom), A. Aujayeb (Newcastle upon Tyne, United Kingdom)
| |
Changes in heart rate variability during psychological stress in cardiorespiratory failure patients
G. Luna Rodríguez (Mexico, Mexico), V. Pelaéz- Hernandéz (Mexico, Mexico), L. Martínez-Bautista (Mexico, Mexico), K. Rosales-Castillo (Mexico, Mexico), K. Santillán-Reyes (Mexico, Mexico), A. Orea-Tejeda (Mexico, Mexico), M. Gómez-Martínez (Mexico, Mexico), R. Sánchez-Santillán (Mexico, Mexico), J. Orozco-Gutierrez (Mexico, Mexico), I. Pérez-García (Mexico, Mexico), N. Martínez-Luna (Mexico, Mexico), Y. Gastelum-Ayala (Mexico, Mexico)
| |